Header cover image

Australian (ASX) Biotech Industry Analysis

UpdatedJun 03, 2024
DataAggregated Company Financials
Companies33
  • 7D0.3%
  • 3M2.5%
  • 1Y-7.0%
  • YTDn/a

The Biotech is pretty flat in the last 7 days, but Telix Pharmaceuticals has stood out, gaining 17%. As for the longer term, the industry has declined 7.1% in the last year. Looking forward, earnings are forecast to grow by 16% annually.

Industry Valuation and Performance

Has the Australian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 03 Jun 2024AU$146.4bAU$22.1bAU$3.2b31.4x45.4x6.6x
Wed, 01 May 2024AU$143.4bAU$22.5bAU$3.3b30.2x43.5x6.4x
Fri, 29 Mar 2024AU$147.5bAU$22.6bAU$3.3b30.2x44.5x6.5x
Sun, 25 Feb 2024AU$144.9bAU$22.4bAU$3.3b36.6x43.7x6.5x
Tue, 23 Jan 2024AU$147.7bAU$20.8bAU$2.8b34x53.5x7.1x
Thu, 21 Dec 2023AU$144.3bAU$20.3bAU$2.7b34.6x53.9x7.1x
Sat, 18 Nov 2023AU$131.6bAU$21.1bAU$2.8b31.9x46.8x6.2x
Mon, 16 Oct 2023AU$123.8bAU$21.8bAU$2.9b29.8x43.2x5.7x
Wed, 13 Sep 2023AU$138.5bAU$21.4bAU$2.8b32.7x49.4x6.5x
Fri, 11 Aug 2023AU$135.6bAU$18.3bAU$2.4b36.8x57.1x7.4x
Sun, 09 Jul 2023AU$137.4bAU$18.0bAU$2.3b36.7x59.2x7.6x
Tue, 06 Jun 2023AU$158.6bAU$18.2bAU$2.4b41x67.1x8.7x
Thu, 04 May 2023AU$153.6bAU$18.0bAU$2.3b41.2x66x8.5x
Sat, 01 Apr 2023AU$146.9bAU$18.0bAU$2.3b40.1x63.4x8.2x
Mon, 27 Feb 2023AU$152.5bAU$17.7bAU$2.3b44.9x66.4x8.6x
Wed, 25 Jan 2023AU$152.1bAU$15.3bAU$2.4b54.3x62.8x9.9x
Fri, 23 Dec 2022AU$148.4bAU$16.0bAU$2.5b46.4x58.2x9.3x
Sun, 20 Nov 2022AU$150.5bAU$16.1bAU$2.6b43.5x58.9x9.4x
Tue, 18 Oct 2022AU$142.9bAU$17.2bAU$2.8b40.5x51.4x8.3x
Thu, 15 Sep 2022AU$147.7bAU$15.9bAU$2.5b46.4x58.3x9.3x
Sat, 13 Aug 2022AU$149.6bAU$15.2bAU$2.7b41.7x55x9.9x
Mon, 11 Jul 2022AU$145.5bAU$15.7bAU$2.8b38x51.3x9.3x
Wed, 08 Jun 2022AU$135.2bAU$15.0bAU$2.7b35.2x50.1x9x
Fri, 06 May 2022AU$139.6bAU$15.1bAU$2.7b37.1x50.8x9.3x
Sun, 03 Apr 2022AU$135.7bAU$14.4bAU$2.6b39.1x52.2x9.5x
Tue, 01 Mar 2022AU$133.5bAU$14.9bAU$2.6b40.2x51.5x9x
Thu, 27 Jan 2022AU$133.1bAU$14.7bAU$2.8b37.2x47.6x9.1x
Sat, 25 Dec 2021AU$152.1bAU$14.5bAU$2.8b42.7x55.2x10.5x
Mon, 22 Nov 2021AU$156.9bAU$14.4bAU$2.7b43.9x57.4x10.9x
Wed, 20 Oct 2021AU$147.3bAU$14.1bAU$2.7b42.1x55.3x10.4x
Fri, 17 Sep 2021AU$153.1bAU$14.3bAU$2.7b43.3x56.8x10.7x
Sun, 15 Aug 2021AU$146.2bAU$14.0bAU$2.6b42.7x55.7x10.5x
Thu, 10 Jun 2021AU$142.6bAU$13.5bAU$2.8b39.9x50.3x10.5x
Price to Earnings Ratio

50.3x


Total Market Cap: AU$142.6bTotal Earnings: AU$2.8bTotal Revenue: AU$13.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Biotech Industry Price to Earnings3Y Average 54x202220232024
Current Industry PE
  • Investors are pessimistic on the Australian Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 45.4x which is lower than its 3-year average PE of 54.0x.
  • The 3-year average PS ratio of 8.5x is higher than the industry's current PS ratio of 6.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have grown 4.4% per year over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Australian Biotech compare with similar industries?

AU Market-0.33%
Healthcare0.41%
Biotech0.35%
Biotech0.35%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TLX Telix PharmaceuticalsAU$18.2514.9%
+AU$855.5m		66.1%PE1183x
CSL CSLAU$281.340.2%
+AU$338.3m		-9.5%PE36.6x
DXB DimerixAU$0.5118.8%
+AU$44.0m		642.6%PS30.4x
RAC Race OncologyAU$1.6513.0%
+AU$34.4m		16.2%PS48.1x
ARX Aroa BiosurgeryAU$0.566.7%
+AU$12.0m		-38.3%PS3x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CYP

AU$0.32

Cynata Therapeutics

7D

10.3%

1Y

120.7%

Will Cynata Therapeutics (ASX:CYP) Spend Its Cash Wisely?

May 29
Will Cynata Therapeutics (ASX:CYP) Spend Its Cash Wisely?

BDX

AU$0.14

BCAL Diagnostics

7D

20.8%

1Y

45.0%

OPT

AU$0.52

Opthea

7D

-16.3%

1Y

-11.2%

TLX

AU$18.25

Telix Pharmaceuticals

7D

14.9%

1Y

66.1%

ARX

AU$0.56

Aroa Biosurgery

7D

6.7%

1Y

-38.3%

CHM

AU$0.019

Chimeric Therapeutics

7D

-13.6%

1Y

-52.5%

CSL

AU$281.34

CSL

7D

0.2%

1Y

-9.5%

PYC

AU$0.10

PYC Therapeutics

7D

-13.0%

1Y

81.8%

RAC

AU$1.65

Race Oncology

7D

13.0%

1Y

16.2%

ACW

AU$0.029

Actinogen Medical

7D

16.0%

1Y

-39.6%

PAR

AU$0.25

Paradigm Biopharmaceuticals

7D

-5.7%

1Y

-69.9%

KZA

AU$0.08

Kazia Therapeutics

7D

-27.3%

1Y

-17.5%

IMU

AU$0.064

Imugene

7D

-9.9%

1Y

-39.0%

MSB

AU$1.11

Mesoblast

7D

-4.3%

1Y

1.4%

DXB

AU$0.51

Dimerix

7D

18.8%

1Y

642.6%

CUV

AU$15.16

Clinuvel Pharmaceuticals

7D

-2.9%

1Y

-19.7%